2 rapidly growing small cap ASX shares to buy
James Mickleboro | April 5, 2021 9:45am |
More on: Image source: Getty Images
If you’re interested in adding some exposure to the small side of the market to your portfolio then you might want to take a look at the shares listed below.
Here’s why these ASX small caps have been tipped as buys:
Universal Store Holdings Limited
The first small cap to look at is Universal Store. It is a fashion retailer which delivers an ever-changing and carefully curated selection of on-trend products to the younger fashion-focused customer.
Universal Store has been an exceptionally strong performer during the pandemic. This culminated in the company delivering a half year result in February which revealed stellar sales and profit growth. For the six months ended 31 December, Universal Store posted a 23.3% increase in sales to $118 million and a massive 63.6% increase in underlying net profit after tax to $21.1 million.
3 ASX shares to buy in April 2021
Tristan Harrison | April 1, 2021 11:48am |
More on:
There are some ASX shares that could be really compelling ideas to look at in April 2021.
Opportunities are always presenting themselves as share prices change, results are revealed and new business announcements are made.
This month could be the time to look at the following three ASX shares:
Temple & Webster has a goal of becoming the largest retailer furniture and homewares in its home market.
The company can point to several tailwinds that are helping accelerate its growth. There’s the long-term adoption of online shopping, an acceleration of that trend due to COVID-19, a higher level of discretionary spending because of travel restrictions (and higher saving) and finally there’s the strength of the housing market and unemployment levels.
Is it time to buy these 2 hot ASX healthcare shares?
Tristan Harrison | March 1, 2021 5:08pm |
More on:
There are some ASX healthcare shares that are creating a lot of growth at the moment. Is it time to buy them?
Healthcare is one of the largest sectors on the ASX with a number of major companies with global earnings such as
Ramsay Health Care Limited (ASX: RHC) and
But there are some smaller ones that are expanding their market share and growing revenue:
Volpara is a medical technology business that provides clinical functions for screening clinics provide feedback on breast density, compression, dose, and quality, while its enterprise-wide practice-management software helps with productivity, compliance, reimbursement and patient tracking.
2 growing small cap ASX shares to buy
Tristan Harrison | February 4, 2021 5:15pm |
More on:
Growing small cap ASX shares could be worth researching for potential long-term returns.
Smaller businesses may have the ability to create attractive performance for investors compared to large businesses which have already experienced a lot of growth.
These are two companies that could be worth some attention:
Healthia describes itself as an integrated group of health-based businesses.
It owns Australia’s largest podiatry group, called My FootDr. The clinics are equipped with advanced equipment, which the business claims makes them the most modern podiatry centres in Australia. Healthia also offers other services including physiotherapy, hand and upper limb rehabilitation, orthotic manufacturing (iOrthotics) and podiatry and foot care product distribution (DBS Medical Supplies).
2 exciting small cap ASX shares to buy
Tristan Harrison | January 16, 2021 11:45am |
More on:
Some small cap ASX shares may be able to make good returns over the longer-term.
There are smaller businesses that have interesting characteristics, which may be of interest to some investors:
Volpara is a medical technology business. Its main service is providing software to help detect breast cancer early on by increasing the quality of screening using AI.
The small cap ASX share reported its FY21 half-year result a couple of months ago. Subscription revenue went up 71% to NZ$8.8 million, though total revenue only grew by 38% to NZ$9.5 million. Annual recurring revenue (ARR) went up from NZ$18 million to NZ$19.9 million.